Overview
Daniel Davis practices in London, United Kingdom. Mr. Davis is rated as an Experienced expert by MediFind in the treatment of Chediak-Higashi Syndrome. His top areas of expertise are Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome) and Chediak-Higashi Syndrome.
His clinical research consists of co-authoring 69 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chediak-Higashi Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chediak-Higashi SyndromeMr. Davis isExperienced. Learn about Chediak-Higashi Syndrome.
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)